Imetelstat as Maintenance Therapy After Initial Induction Chemotherapy in Non-small Cell Lung Cancer (NSCLC)
Public ClinicalTrials.gov record NCT01137968. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Phase II Study of Imetelstat as Maintenance Therapy After Initial Induction Chemotherapy for Advance Non-small Cell Lung Cancer(NSCLC)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this is to evaluate the efficacy and safety of imetelstat (GRN163L) as maintenance therapy for patients with advanced stage NSCLC who have not progressed after 4 cycles of platinum based therapy. Participants will be randomized in a 2:1 ratio to imetelstat + standard of care versus standard of care alone. Participants who received bevacizumab with their induction chemotherapy will continue to receive bevacizumab on this study.
Study identification
- NCT ID
- NCT01137968
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 116 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2010 (Type not available)
- Primary completion
- Sep 2013 (Actual)
- Completion
- Sep 2013 (Actual)
- Last update posted
- Jan 26, 2016
2010 – 2013
United States locations
- U.S. sites
- 26
- U.S. states
- 17
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Achieve Clinical Research, Llc | Birmingham | Alabama | 35216 | — |
| Clearview Cancer Institute | Huntsville | Alabama | 35805 | — |
| Pacific Cancer Medical Center, Inc. | Anaheim | California | 92801 | — |
| Cancer Care Associates of Fresno Medical Group Inc | Fresno | California | 93720 | — |
| St. Joseph's Hospital | Orange | California | 92868 | — |
| Kaiser Permanente Medical Center | Vallejo | California | 94589 | — |
| University of Colorado Denver School of Medicine | Aurora | Colorado | 80045 | — |
| Florida Cancer Specialists | Fort Myers | Florida | 33901 | — |
| Integrated Community Oncology Network | Jacksonville | Florida | 32256 | — |
| H. Moffitt Lee Cancer Center | Tampa | Florida | 33612 | — |
| Ingalls Memorial Hospital | Harvey | Illinois | 60426 | — |
| Cancer Center of Kansas | Wichita | Kansas | 67214 | — |
| Montgomery Cancer Center | Mount Sterling | Kentucky | 40353 | — |
| Auerbach Hematology Oncology | Baltimore | Maryland | 21237 | — |
| Karmanos Cancer Institute | Detroit | Michigan | 48201 | — |
| Hematology Oncology Centers | Billings | Montana | 59101 | — |
| Blumenthal Cancer Center | Charlotte | North Carolina | 28204 | — |
| Kaiser Northwest | Portland | Oregon | 97227 | — |
| South Carolina Oncology Associates | Columbia | South Carolina | 29210 | — |
| The Jones Clinic | Germantown | Tennessee | 38138 | — |
| Sarah Cannon Research Institute | Nashville | Tennessee | 37203 | — |
| UT Southwestern Medical Center | Dallas | Texas | 75390 | — |
| Scott and White Memorial Hospital (Texas A & M) | Temple | Texas | 76508 | — |
| Swedish Cancer Institute | Seattle | Washington | 98104 | — |
| Northwest Medical Specialties | Tacoma | Washington | 98405 | — |
| University of Wisconsin | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01137968, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 26, 2016 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01137968 live on ClinicalTrials.gov.